Images List Premium Download Classic

Bowel

Bowel-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
October 05, 2017 - N°20170286620

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
October 05, 2017 - N°20170286619

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Treatment of constipation-predominant irritable bowel syndrome
Forest Laboratories Holdings Limited
October 05, 2017 - N°20170281722

The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Intra-vaginal devices and methods for treating fecal incontinence
Pelvalon, Inc.
October 05, 2017 - N°20170281325

Devices and methods for intra-vaginal bowel control.
Gas-monitoring apparatus for detecting bowel movements and method of use
Sensor Technologies, Llc
September 28, 2017 - N°20170278373

A room monitoring device designed and intended to detect a bowel movement (bm) of a person occupying the room, such as a baby or infant or an adult with special needs or in a care facility. The device tests the air for particular substances such as, but not limited to, methane and hydrogen sulfide. The test is performed multiple times ...
Antibodies that bind il-23
Eli Lilly And Company
September 28, 2017 - N°20170275356

The present invention provides an antibody that binds to the p19 subunit of human il-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft-versus-host ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270272

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270271

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270270

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270269

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Method and system for microbiome-derived diagnostics and therapeutics
Ubiome, Inc.
September 21, 2017 - N°20170270268

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted ...
Modulation of tissue transglutaminase activation in disease
The Board Of Trustees Of The Leland Stanford Junior University
September 21, 2017 - N°20170266198

Compositions and methods are provided for modulating the physiological activation of tissue transglutaminase (tg2); which methods can include inhibiting the activation of tg2 associated with enteric inflammatory disorders, which disorders may include celiac disease, irritable bowel syndrome, crohn's disease, dermatitis herpetiformis, and the like. In other embodiments of the invention, methods are provided for reducing undesirable paracellular transport in enteric ...
Targeting systems for providing accurate placement of magnetic anastomosis devices
Gi Windows, Inc.
September 21, 2017 - N°20170265866

The invention provides a system for providing improved placement of magnetic compression devices at a desired target site so as to create anastomoses between tissues. The system includes a targeted member or medium configured to be placed within a hollow body of a patient. The hollow body may include, but is not limited to, the stomach, gallbladder, pancreas, duodenum, small ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Background-suppressed, reduced field-of-view radial magnetic resonance imaging
Northshore University Healthsystem
September 14, 2017 - N°20170261581

Embodiments relate to a method and system to improve fat suppression and reduce motion and off-resonance artifacts in magnetic resonance imaging (mri) by using a background-suppressed, reduced field-of-view (fov) radial imaging. The reduction of such artifacts provides improved diagnostic image quality, higher throughput of mri scans for the imaging center, and increased patient comfort. By using a small fov radial ...
Amine polymers for use as bile acid sequestrants
Relypsa, Inc.
September 14, 2017 - N°20170258825

The present invention provides crosslinked amine polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritus, irritable bowel syndrome-diarrhea (ibs-d), bile acid malabsorption, and the like.
Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
Nestec S.a.
September 07, 2017 - N°20170254806

The present invention provides methods for predicting whether an individual having inflammatory bowel disease (ibd) is likely to respond to vedolizumab treatment. Also provided are methods for predicting whether an individual with ibd such as crohn's disease or ulcerative colitis will develop autoantibodies against vedolizumab. The present invention also provides a treatment regimen for an ibd patient which includes measuring ...
Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
Nogra Pharma Limited
September 07, 2017 - N°20170253880

The invention relates to antisense oligonucleotidic sequences (odn) against smad7 suitably modified, and their uses in medical field as therapeutic biological agents, in particular in the treatment of chronic inflammatory bowel disease, such as crohn's disease and ulcerative colitis.
Heterocyclic compound
Nogra Pharma Limited
September 07, 2017 - N°20170253591

[wherein each symbol is as described in the description] or a salt thereof, which has an rorγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.
Pyrazolothiazole compound and medicine comprising same
Nogra Pharma Limited
September 07, 2017 - N°20170252341

The compound of the invention has jak1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect and anti-proliferative effect, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis and vasculitis, bronchial asthma, chronic obstructive pulmonary disease and eosinophilic sinusitis, nasal polyp.
Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
Vetica Labs, Inc.
August 31, 2017 - N°20170248614

The present invention provides methods and systems to accurately detect and measure levels of endogenous antibodies, for examples endogenous iga, to particular antigens in a biological sample from a companion animal, which is useful to diagnose inflammatory conditions, including bowel disease (ibd), gastrointestinal infections, and food sensitivities in companion animals, e. G., dogs or cats, and to distinguish among such ...
Use of anti-eotaxin antibodies for treating inflammatory bowel disease
Immune Pharmaceuticals Ltd.
August 31, 2017 - N°20170247442

The present invention provides use of one or more complementary determining regions (cdrs) of the cat-212-213 vh and/or vl domains in non-native antibody framework regions, or, alternatively, the whole vh, vl, or cat-212 antibody, in treating inflammatory diseases in a subject, such as inflammatory bowel disease.
Loading